Evidence Based Medicine presented by InpharmD™ podcast

Ketamine for Sickle Cell Disease

8/28/2024

Evidence Based Medicine presented by InpharmD™

0:00

13:02

InpharmD's EBM podcast focuses on commonly asked drug information questions and the associated literature. This episode focuses on the use of ketamine for Sickle Cell Disease.

More episodes from "Evidence Based Medicine presented by InpharmD™"

Ketamine for Sickle Cell Disease
8/28/2024
13:02
InpharmD's EBM podcast focuses on commonly asked drug information questions and the associated literature. This episode focuses on the use of ketamine for Sickle Cell Disease.
Tirzepatide for Sleep Apnea
7/26/2024
11:02
InpharmD's EBM podcast focuses on commonly asked drug information (DI) questions and the associated literature. Everyday, our queue gets tons of questions asked by health care providers all around the country. For this episode, we assess tirzepatide for obstructive sleep apnea and analyze the SURMOUNT-OSA clinical trials.
Don't miss an episode of “Evidence Based Medicine presented by InpharmD™” and subscribe to it in the GetPodcast app.
Excoriation Disorder
5/28/2024
10:50
InpharmD's EBM podcast focuses on commonly asked drug information (DI) questions and the associated literature. Everyday, our queue gets tons of questions asked by health care providers all around the country. For this episode, we assess treatment options for excoriation disorder.
Phenytoin for Tacrolimus Toxicity
4/25/2024
14:00
InpharmD's EBM podcast focuses on commonly asked DI questions. Every day, our queue gets tons of new questions asked from providers all around the country. Today's podcast focuses on the use of phenytoin to treat tacrolimus toxicity.
Atypical Antipsychotics and QT–prolongation
2/27/2024
11:08
InpharmD's EBM podcast focuses on commonly asked drug information questions. Every day, our queue gets tons of new questions asked from providers all around the country. One question that’s been garnering a lot of views from our users right now is which atypical antipsychotics are associated with the lowest and highest risk of QT prolongation.
Apixaban in Peripheral Artery Disease
11/30/2023
10:30
Join InpharmD as we discuss the role of apixaban in peripheral artery disease.
Safety and Efficacy of RSV Vaccines
9/27/2023
9:59
Join InpharmD as we discuss the safety and efficacy of two FDA-approved RSV vaccines, Arexvy and Abrysvo.
Safety and Efficacy of Rezafungin
7/20/2023
9:41
Join us as we discuss the data surrounding newly approved antifungal agent, rezafungin. Interested in learning more? Join our CE on rezafungin on July 27th at 12:00 PM EST - open to all pharmacists!
Perioperative Duloxetine During Orthopedic Surgery for Pain Reduction
6/13/2023
8:26
Join InpharmD as we discuss the data on perioperative duloxetine (Cymbalta) during orthopedic surgery for pain reduction. Interested in the full data response? Read here!
Lecanemab in the treatment of Alzheimer’s Dementia
4/17/2023
9:28
Every month, InpharmD creates a continuing-education (CE) class on the most commonly asked drug information question and the related evidence. Our podcast offers a sneak peak into our CE as we briefly discuss the topic. Episode-2 looks at the safety and efficacy of lecanemab in the treatment of Alzheimer’s dementia.

More Episodes

Get the whole world of podcasts with the free GetPodcast app.

Subscribe to your favorite podcasts, listen to episodes offline and get thrilling recommendations.

Ketamine for Sickle Cell Disease

Evidence Based Medicine presented by InpharmD™

More episodes from "Evidence Based Medicine presented by InpharmD™"

Ketamine for Sickle Cell Disease

Tirzepatide for Sleep Apnea

Excoriation Disorder

Phenytoin for Tacrolimus Toxicity

Atypical Antipsychotics and QT–prolongation

Apixaban in Peripheral Artery Disease

Safety and Efficacy of RSV Vaccines

Safety and Efficacy of Rezafungin

Perioperative Duloxetine During Orthopedic Surgery for Pain Reduction

Lecanemab in the treatment of Alzheimer’s Dementia